DENALI THERAPEUTICS INC (DNLI)
US24823R1059 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to DNLI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 44.43. This target is 175.22% above the current price.
DNLI was analyzed by 23 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about DNLI.
In the previous month the buy percentage consensus was at a similar level.
DNLI was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-09 | UBS | Maintains | Buy -> Buy |
| 2024-02-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-02-28 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-13 | Citigroup | Initiate | Buy |
| 2023-11-20 | JP Morgan | Reiterate | Overweight |
| 2023-11-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-09-06 | B. Riley Securities | Initiate | Buy |
| 2023-08-31 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-09 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-06-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-05-09 | Wedbush | Maintains | Outperform |
| 2023-05-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-12 | Morgan Stanley | Maintains | Overweight |
| 2023-03-02 | Oppenheimer | Maintains | Outperform |
| 2023-03-01 | Morgan Stanley | Maintains | Overweight |
| 2023-02-28 | Wedbush | Maintains | Outperform |
| 2023-02-28 | Evercore ISI Group | Maintains | Outperform |
| 2023-02-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-23 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-30 | SVB Leerink | Initiate | Outperform |
| 2023-01-25 | Morgan Stanley | Maintains | Overweight |
| 2022-12-05 | Cowen & Co. | Initiate | Outperform |